129.48
+1.27
+(0.99%)
At close: April 17 at 4:00:02 PM EDT
129.99
+0.51
+(0.39%)
After hours: April 17 at 6:57:27 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 12 | 12 | 13 | 12 |
Avg. Estimate | 2.88 | 3.46 | 14.09 | 15.26 |
Low Estimate | 2.71 | 3.36 | 13.79 | 14.81 |
High Estimate | 3.18 | 3.59 | 14.22 | 15.59 |
Year Ago EPS | 3.21 | 3.42 | 14.01 | 14.09 |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 11 | 11 | 14 | 14 |
Avg. Estimate | 699.37M | 760.7M | 3.06B | 3.21B |
Low Estimate | 697.9M | 749.2M | 3.03B | 3.15B |
High Estimate | 703M | 774.8M | 3.13B | 3.56B |
Year Ago Sales | 737.85M | 749.69M | 3.05B | 3.06B |
Sales Growth (year/est) | -5.22% | 1.47% | 0.46% | 4.86% |
Earnings History
Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
---|---|---|---|---|
EPS Est. | 3.07 | 3.33 | 3.39 | 3.88 |
EPS Actual | 3.21 | 3.42 | 3.49 | 3.89 |
Difference | 0.14 | 0.09 | 0.1 | 0.02 |
Surprise % | 4.67% | 2.66% | 2.88% | 0.39% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 2.88 | 3.46 | 14.09 | 15.26 |
7 Days Ago | 2.88 | 3.46 | 14.11 | 15.3 |
30 Days Ago | 2.96 | 3.49 | 14.2 | 15.42 |
60 Days Ago | 3.51 | 3.7 | 15.21 | 16.73 |
90 Days Ago | 3.51 | 3.71 | 15.23 | 16.73 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | -- | -- |
Up Last 30 Days | -- | 1 | -- | -- |
Down Last 7 Days | 1 | 1 | 1 | 2 |
Down Last 30 Days | 5 | 4 | 5 | 4 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
TFX | -10.15% | 1.10% | 0.55% | 8.34% |
S&P 500 | 6.92% | 5.09% | 8.78% | 14.15% |
Upgrades & Downgrades
Maintains | Truist Securities: Hold to Hold | 4/11/2025 |
Reiterates | Citizens Capital Markets: Market Perform to Market Perform | 4/2/2025 |
Reiterates | Needham: Hold to Hold | 3/12/2025 |
Maintains | Morgan Stanley: Overweight to Overweight | 3/5/2025 |
Downgrade | B of A Securities: Neutral to Underperform | 3/4/2025 |
Maintains | Truist Securities: Hold to Hold | 3/3/2025 |
Related Tickers
WST West Pharmaceutical Services, Inc.
201.90
-3.46%
COO The Cooper Companies, Inc.
79.51
+1.64%
NVST Envista Holdings Corporation
15.18
+1.07%
AVTR Avantor, Inc.
15.10
-0.98%
HOLX Hologic, Inc.
57.56
+1.88%
UTMD Utah Medical Products, Inc.
52.30
-0.19%
ATR AptarGroup, Inc.
143.83
-0.81%
RGEN Repligen Corporation
130.00
-1.59%
ICUI ICU Medical, Inc.
138.67
-0.34%
RMD ResMed Inc.
212.91
+0.67%